newsfilter
← Latest News
GlobeNewswire·

Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update

Surpassed 50% Enrollment Milestone in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104Company Anticipates Completion of Patient Enrollment in the STRIVE-ON Trial in Late 2024 to Early 2025, with NDA Submission on Track